Verinata Health, Inc. v. Ariosa Diagnostics, Inc., No. 18-2198 (Fed. Cir. Apr. 24, 2020)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

After trial on the merits, a jury found two U.S. patents valid and infringed. Ariosa Diagnostics, Inc., and Roche Molecular Systems, Inc. , moved for judgment as a matter of law on in validity and noninfringement. Verinata Health, Inc., and Illumina, Inc., moved for a permanent in- junction, supplemental damages, an accounting, and pre- and post-judgment interest. The district court denied the parties’ motions. Verinata and Illumina appeal the denial of the permanent injunction, supplemental damages, an ac- counting, and pre -judgment interest.